Andrx Relinquishes 180-Day Exclusivity For Wellbutrin Generic, Ceding Ground To Eon
Generic drug maker Andrx Corp. has relinquished its right to a 180-day period of marketing exclusivity for the 150mg strength of Wellbutrin SR(R), a best-selling antidepressant from GlaxoSmithKline....To view the full article, register now.
Already a subscriber? Click here to view full article